明星抗癌药上半年海外大卖1.6亿美元,李嘉诚旗下和黄医药总收入却下滑,原因何在?

时代财经
Aug 08

本文来源:时代财经 作者:张羽岐图片来源:图虫创意8月7日晚间,李嘉诚家族企业和黄医药(00013.HK;HCM.US)发布2025年上半年业绩。财报数据显示,今年上半年,和黄医药总收入为2.777亿美元,去年同期为3.057亿美元。此外,2025年上半年,和黄医药应占净收益为4.55亿美元,去年上半年这一数字为2580万美元。和黄医药执行董事、首席执行官兼首席科学官苏慰国在8月8日上午举行的...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10